press
Elite Summit 2019 – Interview with our Managing Partner Christoph Kausch
May 27, 2019 + Jessica Di Palo
7 Min read
What Makes Healthcare Technology Attractive to Investors
The Elite Summit is the premium forum bringing top tier buyers and sellers together. The Summit offers the independent advisors of wealthy private investors and international fund and asset managers an intimate environment for focused discussion of the key new drivers shaping wealth management asset allocation. Taking place at the Fairmont Le Montreux Palace, Montreux, Switzerland, 12 – 14 June, the Summit includes presentations on understanding the markets to anticipate the future, exploring the alternative investment market, ensuring the successful execution of the family vision and principles, and creating firm family succession.
Share the Article
Leading brands revolutionize care journeys with Lumeon
How Lumeon orchestrates care journey
Trialbee – our hero in patient matching and recruiting for clinical trials
Trialbee - patient matching and recruiting
Digital healthcare: patient-first?
Digital Healthcare Report 2021 in collaboration with Dealroom and INKEF Capital
SFDR – How does MTIP approach the EU’s Sustainable Disclosure Regulation?
New SFDR obligations
MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation
First Closing of Fund II
MTIP invests in Koa Health to make mental health treatment more accessible
New investment in Koa Health
MTIP scored fantastic grades in the UNPRI assessment report of 2020
UNPRI Report grades 2020
4 Health VCs Share Their Business Priorities and What is Next
Interview Techtour
TytoCare closes $50 million round as the demand for telehealth accelerates
TytoCare closes new round
The digital healthtech sector is expanding – and so are we!
Two new empolyees start in April
MTIP has sucessfully exited Blueprint Genetics
Blueprint exit January 2020
Whitepaper: A positive prognosis for the future of healthtech
Our first Whitepaper
Elite Summit 2019 – Interview with our Managing Partner Christoph Kausch
Elite Summit 2019
New MTIP investment in Quanta Dialysis Technologies
New investment in Quanta
Interview with Christoph Kausch in biotechandmoney
interview Bioandtechnology
New MTIP investment – Nitinotes Series A Round
New investment in Nitinotes
New investment in an Israeli based digital health company TytoCare
New investment in TytoCare